fda approved indications for semaglutide FDA-Approved Dosages and GLP-1 and Dual GIP/GLP-1 Ozempic, Wegovy, and Mounjaro: Prescribing

Non-diabetic men prescribed semaglutide were significantly more likely to develop erectile dysfunction and/or were prescribed phosphodiesterase type 5 inhibitors (1.47% vs 0.32%

Curious about Zepbound weight loss results

Conventional noninvasive medical management is significantly less effective and durable than MBS, and also, not risk free

Later tests resumed passing purity/fill, but batch identifiers are often missing.

The significant year-over-year (YoY) jump in GLP-1 coverage among the largest companies signals a key shift: the employer debate is moving from whether to cover weight loss drugs to how to do so sustainably.

Unique Properties of Retatrutide: Triple Hormone Agonist:Retatrutide is a novel, triple hormone agonist that simultaneously activates the GLP-1, GIP, and glucagon receptors